Clinical Research Alliance Announces New Partnership With Quality Cancer Care, P.C.
Clinical Research Alliance (CRA), a division of Optimus Healthcare Services (OTC Pink: OHCS), has announced a strategic partnership with Quality Cancer Care, P.C. and Dr. Gardith Joseph to enhance access to oncology clinical trials in Brooklyn, NY. Dr. Joseph, an experienced oncologist, aims to provide her patients with options for participating in clinical trials, focusing on underserved populations. CRA has conducted nearly 200 decentralized trials, seeking to improve access to innovative cancer treatments. This collaboration aligns with CRA's community-focused mission to broaden representation in oncology research.
- Strategic partnership with Quality Cancer Care to expand clinical trials.
- Dr. Joseph brings 21 years of oncology experience, enhancing trial access.
- CRA has conducted close to 200 decentralized trials, benefiting thousands.
- None.
Combining decades of expertise in delivering premier oncology care and expanding patient access to clinical trials.
NEW YORK, NY / ACCESSWIRE / February 9, 2023 / Clinical Research Alliance (CRA), a division of Optimus Healthcare Services, Inc. (OTC Pink:OHCS), announced a new strategic partnership with Quality Cancer Care, P.C., and Dr. Gardith Joseph. Together, CRA and Dr. Joseph aim to leverage her 21 years of experience specializing in oncology in Brooklyn, N.Y. with CRA's mission to expand clinical trials to an underserved population that historically has not been well represented in oncology clinical trials. Dr. Joseph has extensive experience with breast, gastrointestinal, and hematologic cancers. Dr. Joseph earned her medical degree from Universidad de Sevilla FOM and maintains affiliations with New York-Presbyterian, Brooklyn Methodist Hospital, and Brookdale Hospital Medical Center.
Dr. Joseph had this to say, referring to this emerging partnership; "CRA provides my patients with the choice of participating in clinical trials. I am excited at this opportunity to further assist our community."
CRA has a community-oriented mindset that is focused on helping underserved communities and patient populations. This mission is precisely what we aim to further achieve by bringing Dr. Joseph into the fold. CRA is comprised of dedicated physicians and healthcare professionals that are committed to providing patients with the opportunity to participate in clinical trials testing potential cancer treatments in their local communities. Dr. Joseph's decades of experience in the oncology field will help bring these clinical trials to her patients in Brooklyn. N.Y. CRA has participated in close to 200 decentralized trials delivering access to thousands of patients, and we look forward to the great work we can accomplish in conjunction with Dr. Joseph.
"We are pleased to partner with Dr. Joseph. She represents the physicians that CRA seeks strategic partnerships with. Dr. Joseph is committed to providing much needed care to the Brooklyn, N.Y. community. We look forward to providing her patients with access to much needed oncology clinical trials" said John Sganga, President and CEO of CRA.
About Clinical Research Alliance
CRA enables access to clinical trial research-making it easier for patients and providers to participate and accelerating the development of new and innovative cancer treatments that impact patient lives. By helping to provide state-of-the-art clinical trial research in a community setting, CRA also makes clinical research more accessible to underserved populations that enable faster enrollment, better retention and a patient population that is representative of real-world populations.
LinkedIn: clinical-research-alliance | Instagram: @clinicalresearchalliance | Facebook: @ClinicalResearchAlliance | https://www.clinicalresearchalliance.org/
Caution Concerning Forward Looking Statements:
This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not a guarantee of future actions or performance. These forward-looking statements are based on information currently available to Optimus and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning Optimus's business are described in Periodic and Current Reports filed with the OTCIQ and the SEC. Optimus is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Cliff Saffron, Chief Financial Officer
csaffron@theoptimushealthcare.com
516-806-4201
SOURCE: Optimus Healthcare Services, Inc.
View source version on accesswire.com:
https://www.accesswire.com/738600/Clinical-Research-Alliance-Announces-New-Partnership-With-Quality-Cancer-Care-PC
FAQ
What is the purpose of CRA's partnership with Quality Cancer Care?
Who is Dr. Gardith Joseph in relation to the OHCS press release?
How many decentralized trials has CRA conducted?
What communities does CRA aim to serve through its initiatives?
